Forrest, Robin

Number of items: 5.
Health Policy
  • Forrest, Robin Jack (2025). The trade‑off between faster access and evidentiary certainty in the FDA’s Accelerated Approval of cancer drugs: empirical evidence on patient preferences and regulatory decision‑making [Doctoral thesis]. London School of Economics and Political Science. https://doi.org/10.21953/lse.00004962 picture_as_pdf
  • Forrest, Robin, Lagarde, Mylene, Aggarwal, Ajay, Naci, Huseyin (2024). Preferences for speed of access versus certainty of the survival benefit of new cancer drugs: a discrete choice experiment. The Lancet Oncology, 25(12), 1635 - 1643. https://doi.org/10.1016/S1470-2045(24)00596-5 picture_as_pdf
  • Forrest, Robin, Naci, Huseyin (2023). Prioritising patients in negotiations over drug pricing. BMJ (Clinical research ed.), 381, https://doi.org/10.1136/bmj.p829
  • Naci, Huseyin, Forrest, Robin, Zhai, Mike, Stofesky, Amanda R., Kesselheim, Aaron S. (2023). Characteristics of prior authorization policies for new drugs in Medicare Part D. JAMA Health Forum, 4(2). https://doi.org/10.1001/jamahealthforum.2022.5610 picture_as_pdf
    • LSE Health
  • Forrest, Robin, Lagarde, Mylene, Aggarwal, Ajay, Naci, Huseyin (2024). Preferences for speed of access versus certainty of the survival benefit of new cancer drugs: a discrete choice experiment. The Lancet Oncology, 25(12), 1635 - 1643. https://doi.org/10.1016/S1470-2045(24)00596-5 picture_as_pdf
  • Forrest, Robin (19 January 2023) The size of the US pharmaceutical market means that the US Food and Drug Administration has a disproportionately large global influence. USApp – American Politics and Policy Blog. picture_as_pdf